Order Article Reprints

Heugenhauser J, Galijasevic M, Mangesius S, Goebel G, Buchroithner J, Erhart F, Pichler J, Widhalm G, Stockhammer G, Iglseder S, et al. MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy. Cancers. 2022; 14(6):1579. https://doi.org/10.3390/cancers14061579

Heugenhauser, Johanna, Malik Galijasevic, Stephanie Mangesius, Georg Goebel, Johanna Buchroithner, Friedrich Erhart, Josef Pichler, Georg Widhalm, Günther Stockhammer, Sarah Iglseder, and et al. 2022. "MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy" Cancers 14, no. 6: 1579. https://doi.org/10.3390/cancers14061579

Heugenhauser, J., Galijasevic, M., Mangesius, S., Goebel, G., Buchroithner, J., Erhart, F., Pichler, J., Widhalm, G., Stockhammer, G., Iglseder, S., Freyschlag, C. F., Oberndorfer, S., Bordihn, K., von Campe, G., Czech, T., Surböck, B., Urbanic Purkart, T., Marosi, C., Felzmann, T., & Nowosielski, M. (2022). MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy. Cancers, 14(6), 1579. https://doi.org/10.3390/cancers14061579